"Designing Growth Strategies is in our DNA"

Orphan Drugs Market Size, Share & Industry Analysis, By Therapy Area (Oncology, Hematology, Neurology, Endocrinology, Cardiovascular, Respiratory, Immunotherapy, Infectious Diseases, and Others), By Drug Type (Biologics and Non-Biologics), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others), and Regional Forecast, 2024-2032

Last Updated: January 20, 2025 | Format: PDF | Report ID: FBI100088

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2023

Estimated Year

2024

Forecast Period

2024-2032

Historical Period

2019-2022

Growth Rate

CAGR of 12.0% from 2024 to 2032

Unit

Value (USD billion)

Segmentation

By Therapy Type

  • Oncology
  • Hematology
  • Neurology
  • Endocrinology
  • Cardiovascular
  • Respiratory
  • Immunotherapy
  • Infectious Diseases
  • Others

By Drug Type

  • Biologics
  • Non-biologics

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

By Region

  • North America (By Therapy Type, By Drug Type, By Distribution Channel, By Country)
    • U.S.
    • Canada
  • Europe (By Therapy Type, By Drug Type, By Distribution Channel, By Country/Sub-Region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Therapy Type, By Drug Type, By Distribution Channel, By Country/Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Rest of the World (By Therapy Type, By Drug Type, By Distribution Channel)
  • 2019-2032
  • 2023
  • 2019-2022
  • 135
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X